GENLISA™ Human SARS-CoV-2 Spike Protein S2 Antigen ELISA (Quantitative)

SKU: KBVH015-18 Category:

48,000.00

ELISA for the quantitative estimation of the SARS-CoV-2 (Covid-19) Spike S2 protein antigen in human serum and plasma samples.


Availability: 2 – 3 Days | Pack Size: 1 x 96 wells



Description

Introduction:
The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be serum, plasma and cell culture supernatant as validated with the kit. The kit employs a sandwich ELISA technique which leads to a higher specificity and increased sensitivity compared to conventional competitive ELISA kits which employ only one antibody. Double antibodies are used in this kit. The spike protein (S-protein) of the SARS-CoV-2 virus is the common target for neutralizing antibodies and vaccines. Spike protein contains two subunits, S1 and S2. S1 contains a receptor binding domain (RBD), which is responsible for recognizing and binding with the cell surface receptor. S2 subunit contains other basic elements needed for the membrane fusion. SARS-CoV-2 (2019-nCoV) (ref.) can infect the human respiratory epithelial cells through interaction with human ACE2. Indeed, the recombinant Spike protein can bind with recombinant ACE2 protein.

Intended Use:
The GENLISA Human SARS-CoV-2 (Covid-19) Spike Protein S2 Antigen ELISA kit is used as an analytical tool for quantitative antigen determination of Human SARS-CoV-2 (Covid-19) spike protein S2 in human serum and plasma.

Principle:
The method employs sandwich ELISA technique. Monoclonal antibodies are pre-coated onto microwells. Samples and standards are pipetted into microwells and Human SARS-CoV-2 (Covid-19) spike protein S2 present in the sample are bound by the capture antibodies. After incubation the wells are washed and followed by HRP- conjugated Detection Antibody is pipetted and incubated to form a complex. After washing microwells in order to remove any non-specific binding, the substrate solution (TMB) is added to microwells and color develops proportionally to the amount of Human SARS-CoV-2 (Covid-19) spike proteins in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.









If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!

View more details about our Publication Reward

Additional information

Species

Human

Sample Type

Serum and Plasma

Calibration Range

15-720 ng/ml

Sensitivity

12 ng/ml

Detection Method

Colorimetric, 450nm

Regulatory Status

For Research Use Only

Research Area

COVID-19